Outsourcing: Does Focus Pay Off?

Publication
Article
BioPharm InternationalBioPharm International-03-15-2018
Volume 2018 eBook
Issue 1
Pages: 4–6

Research suggests that working with a single contract partner can reduce development time and improve economics.

Competitive pressures have led to explosive growth in demand for research and development (R&D) outsourcing, especially as smaller biopharma and pharmaceutical companies play a more prominent role in drug development. Pharmaceutical manufacturers, especially small- to mid-sized companies, are discovering that partnering more closely with one diversified contract company can reduce development time and cost.

Read this article in BioPharm International'sOutsourcing Resources 2018 eBook.

View other articles in BioPharm International's Outsourcing Resources 2018 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2018
March 2018
Pages: 4–6

Citation

When referring to this article, please cite it as A. Shanley, “Outsourcing: Does Focus Pay Off?," BioPharm International Outsourcing Resources eBook (March 2018).

Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content
© 2025 MJH Life Sciences

All rights reserved.